Adenosine for the treatment of paroxysmal supraventricular tachycardia in full-term and preterm newborn infants

American Journal of Perinatology

Volumn 13, Issue 6, 1996, Pages 343-346

  Paret, Gideon ^a   Steinmetz, Danny ^b   Kuint, Jacob ^b   Hegesh, Julius ^b   Frand, Mira ^b   Barzilay, Zohar ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b NONE

Author keywords

atrioventricular node; Supraventricular tachycardia

Indexed keywords

ADENOSINE;

ANTIARRHYTHMIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; HEART ATRIOVENTRICULAR NODE; HUMAN; INFANT; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PREMATURITY; PRIORITY JOURNAL; QRS COMPLEX;

EID: 0029836747     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994353     Document Type: Article

References (18)

1. Sreeram N, Wren C. Supraventricular tachycardia in infants: Response to initial treatment. Arch Dis Child 1989;65:127-9
2. Bertolet BD, Hill JA. Adenosine: Diagnostic and therapeutic uses in cardiovascular medicine. Chest 1993;104:1860-71
3. Camm AJ, Garrat CJ. Adenosine and supraventricular tachycardia. N Engl J Med 1991;325:1624-9
4. Drury AN, Szent-Gyorgyi A. The physiological activity of adenine compounds with special reference to their action upon mammalian heart. J Physiol 1929;68:213-37
5. Rossi AF, Steinberg LG, Kipel G, et al. Use of adenosine in the management of peri-operative arrhythmias in the pediatric cardiac ICU. Crit Care Med 1992;20:1107-11
6. Biaggioni I, Olafsoon B, Robertson RM, et al. Cardiovascular and respiratory effects of adenosine in conscious man: Evidence for chemo-receptor activation. Circ Res 1987;61:779-86
7. Teitel DF. Physiologic development of the cardiovascular system in the fetus. In: Polin RA, Fox WW (eds). Fetal and Neonatal Physiology. New York: Saunders, 1992:609-20
8. Zales VR, Dunnigan A, Benson W. Clinical and electrophysiologic features of fetal and neonatal paroxysmal atrial tachycardia resulting in congestive heart failure. Am J Cardiol 1988;62:225-8
9. Friedman DM, Hoskins IA. Combined ventricular shorten-ing fraction: An echocardiographic index of fetal systolic cardiac function. J Maternal-Fetal Med 1992;1:303-7
10. Fletcher S, Fyfe DA, Gillette PC, Annibelle D. The utility of adenosine to terminate supraventricular tachycardia in a premature hydropic infant. Am Heart J 1991;121:1818-9
11. Clarke B, Till J, Roland G. Rapid and safe termination of SVT in children by adenosine. Lancet 1987;1:299-301
12. Till J, Sheinberd EA, Rigby ML. Efficacy and safety of adenosine in the treatment of SVT in infants and children. Br Heart J 1989;62:201-11
13. Ralston MA, Knicas TK, Henon DW, Daniels SR. Use of adenosine for diagnosis and treatment of tachyarrhythmias in pediatric patients. J Pediatr 1994;124:139-43
14. Overholt ED, Rhouband KS, Goodgisle HP, et al. Usefulness of adenosine for arrhythmias in infants and children. Am J Cardiol 1988;61:333-40
15. Till JA, Sheinborn EA. Supraventricular tachycardia, diagnosis and current acute management. Arch Dis Child 1991;66:647-52
16. Epstein ML, Victoria BE. Cardiac decompression following verapamil therapy in infants with supraventricular tachycardia. Pediatrics 1985;75:737-40
17. Silverbach M, Dunnigan A, Benson DW. Effects of intravenous propranolol and verapamil in infant tachycardia. Am J Cardiol 1989;63:439-42
18. Rankin AC, Goddroyd K, Chong E, et al. Value and limitation of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J 1988;62:195-203